IDG Capital-backed Xiaolu Yiguan, which offers traditional Chinese medicine and health consultancy, has raised 14.5m in a round co-led by Redpoint Ventures and Sinovation Ventures.

Xiaolu Yiguan, a China-based medical consultancy startup backed by media company International Data Group, has secured RMB100m ($14.5m) in series B funding, China Money Network has reported.

Venture capital firms Redpoint Ventures and Sinovation Ventures co-led the round, which followed an undisclosed eight-figure renminbi sum from IDG Capital, the International Data Group VC affiliate that recently bought the company outright, and Morningside Ventures.

Xiaolu Yiguan provides online consultancy for patients suffering from chronic diseases or general poor health, providing treatments…